The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility. (2014)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scisignal.2005157

PubMed Identifier: 25140053

Publication URI: http://europepmc.org/abstract/MED/25140053

Type: Journal Article/Review

Volume: 7

Parent Publication: Science signaling

Issue: 339

ISSN: 1945-0877